Oxcarbazepine

Seizure Management

Oxcarbazepine is primarily used to control partial-onset seizures, which are seizures that start in one specific area of the brain. It is prescribed for patients with epilepsy in two main ways:

• Monotherapy: It can be used alone to treat partial-onset seizures in adults and children who are at least 4 years old.
• Adjunctive therapy: It can be used in combination with other seizure medications to treat partial-onset seizures in adults and children who are at least 2 years old.

This medication works by decreasing abnormal electrical activity in the brain to help prevent seizures from occurring. It is available in several forms, including immediate-release tablets, extended-release tablets, and an oral suspension liquid.

Mechanism of Action

Oxcarbazepine belongs to a class of drugs known as anticonvulsants or antiepileptics. It works by decreasing the abnormal electrical activity in the brain that leads to seizures.

The medication is believed to function by blocking voltage-sensitive sodium channels in nerve cells. This action helps to:

• Stabilize nerve membranes: It prevents nerve cells from becoming overexcited and firing signals too easily.
• Inhibit repetitive firing: By regulating the flow of sodium into neurons, it stops the rapid and excessive electrical discharges that cause a seizure to start or spread.

By calming these overactive nerves, oxcarbazepine helps to restore a more normal balance of electrical signals in the brain.

Common Side Effects

Many people using oxcarbazepine experience mild side effects. These often include:

• Dizziness or drowsiness
• Nausea and vomiting
• Stomach pain
• Tiredness or weakness
• Headache
• Tremors
• Double vision or blurred vision
• Coordination or balance problems

Serious Side Effects

Seek medical attention immediately if you notice any of the following serious symptoms:

• Low sodium levels: This condition, called hyponatremia, can cause confusion, lack of energy, nausea, or more frequent seizures.
• Severe skin reactions: Watch for a skin rash, hives, or blistering and peeling skin, which may be accompanied by a fever.
• Mental health changes: New or worsening depression, anxiety, or thoughts about self-harm.
• Liver problems: Symptoms include yellowing of the eyes or skin, dark urine, or severe stomach pain.
• Allergic reactions: Swelling of the face, lips, tongue, or throat, and difficulty breathing.
• Blood issues: Unusual bruising, tiny purple spots on the skin, or frequent infections.

Serious Skin Reactions

Oxcarbazepine can cause rare but life-threatening skin reactions, such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). These reactions are more likely in individuals of Asian ancestry who have a specific genetic variation known as the HLA-B*1502 allele. Healthcare providers may recommend genetic testing before starting the medication.

Low Sodium Levels

This drug may cause hyponatremia, a condition where blood sodium levels become dangerously low. This is most common during the first three months of treatment. Symptoms can include nausea, headache, confusion, and malaise. Regular blood tests may be required to monitor sodium levels.

Suicidal Ideation

Like other seizure medications, oxcarbazepine may increase the risk of suicidal thoughts or behaviors. It is important to monitor for new or worsening depression, anxiety, or unusual changes in mood.

Hypersensitivity Reactions

Multi-organ hypersensitivity reactions can occur, potentially affecting the liver, kidneys, or blood cells. Individuals who have had a hypersensitivity reaction to carbamazepine have a 25% to 30% chance of having a similar reaction to oxcarbazepine.

Withdrawal Risks

Abruptly stopping oxcarbazepine can lead to an increase in seizure frequency or severe, prolonged seizures. Discontinuation should only occur under the guidance of a healthcare professional, usually through a gradual dose reduction.

Cognitive and Motor Effects

The medication can cause significant drowsiness, dizziness, and coordination problems. These effects may impair the ability to drive or operate heavy machinery, especially when starting the drug or increasing the dose.

Pregnancy

Taking oxcarbazepine during pregnancy may increase the risk of birth defects or other harm to the developing fetus. However, it is important to balance these risks against the potential danger of uncontrolled seizures, which can harm both the pregnant person and the baby.

Key considerations for pregnancy include:

• Medical Consultation: Do not start or stop taking oxcarbazepine without first consulting a healthcare provider. Abruptly stopping seizure medication can lead to serious medical issues.
• Birth Control: Oxcarbazepine can make hormonal contraceptives, such as birth control pills, injections, implants, or skin patches, less effective. This may increase the risk of an unintended pregnancy.
• Pregnancy Registry: There is a North American Antiepileptic Drug Pregnancy Registry that collects information about the safety of seizure medications during pregnancy.

Breastfeeding

Oxcarbazepine and its active components pass into breast milk. Because the potential effects on a nursing infant are not fully understood, it is important to discuss the risks and benefits of breastfeeding with a doctor. Factors to consider include the infant's health and the necessity of the medication for the parent's well-being.

Available Forms

Oxcarbazepine is produced in the following oral formulations:

• Tablets: Standard oral tablets intended for immediate release.
• Extended-release tablets: Tablets designed to release the medication slowly into the body.
• Oral suspension: A liquid form of the medication that is swallowed.

FDA Approval and Indications

Oxcarbazepine was first approved by the U.S. Food and Drug Administration (FDA) in 2000. It is indicated for the treatment of partial-onset seizures in the following capacities:

• Monotherapy: Use as a single-drug treatment for adults and children aged 4 years and older.
• Adjunctive Therapy: Use as an add-on treatment alongside other medications for adults and children aged 2 years and older.

Regulatory Status

Oxcarbazepine is available only by prescription. It is not classified as a controlled substance. While the medication does not have an FDA Boxed Warning, the FDA has issued safety warnings regarding the potential for serious dermatological reactions, including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). These risks are notably higher in patients with the HLA-B*1502 genetic allele, commonly found in individuals of Asian ancestry.

The FDA also monitors the drug for risks associated with hyponatremia (low blood sodium levels) and potential suicidal ideation, which is a warning common to the entire class of antiepileptic drugs. There is currently no Risk Evaluation and Mitigation Strategy (REMS) required for oxcarbazepine.

Risks of Abrupt Discontinuation

Do not stop taking oxcarbazepine without first consulting a healthcare professional, even if you feel well. Suddenly stopping this medication can lead to serious medical complications, including:

• Increased Seizure Frequency: Seizures may occur more often or become more severe if the drug is stopped abruptly.
• Status Epilepticus: Rapid withdrawal of antiepileptic medications can potentially trigger continuous seizures that are difficult to control.

Safe Withdrawal Process

To minimize the risk of increased seizures, oxcarbazepine should generally be withdrawn gradually. A healthcare provider will typically create a tapering schedule to slowly reduce the dose over a period of time. This allows the body to adjust and helps prevent the recurrence of symptoms. If you experience any new or worsening symptoms during this process, contact your doctor immediately.